What is Palvella Therapeutics's capex?

Palvella Therapeutics (PVLA) reported capex of $0 in Q3 2024.

How has Palvella Therapeutics's capex changed year-over-year?

Palvella Therapeutics's capex decreased by 100.0% year-over-year, from $69K to $0.

What is the long-term trend for Palvella Therapeutics's capex?

Over 2 years (2021 to 2023), Palvella Therapeutics's capex has grown at a -56.0% compound annual growth rate (CAGR), from $949K to $184K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Palvella Therapeutics PVLA CapEx

Discontinued — last reported Q3 '24

CapEx at other companies

Relay Therapeutics, Inc.RLAY

$1K—

Viridian Therapeutics, Inc.VRDN

$23K-73.3%

ANI PharmaceuticalsANIP

$6.07M+146%

PrecigenPGEN

$258K-58.5%

Arcutis Biotherapeutics, Inc.ARQT

$0-100%

Kodiak Sciences IncKOD

$942K+249%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Palvella Therapeutics’s 10-Q, filed November 13, 2024, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's capex?: Palvella Therapeutics (PVLA) reported capex of $0 in Q3 2024.
How has Palvella Therapeutics's capex changed year-over-year?: Palvella Therapeutics's capex decreased by 100.0% year-over-year, from $69K to $0.
What is the long-term trend for Palvella Therapeutics's capex?: Over 2 years (2021 to 2023), Palvella Therapeutics's capex has grown at a -56.0% compound annual growth rate (CAGR), from $949K to $184K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.